Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III laryngeal preservation trial comparing TPF induction chemotherapy followed by radiotherapy versus concomitant radiotherapy with cisplatin
2014-005188-34Phase 3Active
- Sponsor
- GORTEC
- Start
- May 2015
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of cisplatin, docetaxel and fluorouracil in head and neck squamous cell carcinoma (HNSCC) (2 arms), sponsored by GORTEC. Started May 2015; status: active.
02
Drugs
cisplatindocetaxelfluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on 2014-005188-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005188-34.